CombinatoRx Declares Positive Results For AR Synavive
CombinatoRx has declared positive results from a Phase-I clinical study, evaluating the relative bioavailability of an oral once-daily aligned-release (AR) formulation of Synavive. The pharmacokinetic profiles observed in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.